ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,107, issued on Jan. 20, was assigned to University of Cincinnati (Cincinnati).

"CpG island methylation profile in non-invasive oral rinse samples for detection of oral and pharyngeal carcinoma" was invented by Scott M. Langevin (Cincinnati) and Karl T. Kelsey (Providence, R.I.).

According to the abstract* released by the U.S. Patent & Trademark Office: "There are currently no screening tests in routine use for oral and pharyngeal cancer beyond visual inspection and palpation. Described is an improve method of detecting oral and pharyngeal cancer with a saliva sample from a subject. The method includes identifying the presence or absence of a methylation classifier in the saliva t...